Respiratory Infections News

COVID-19 survivors face a significantly higher risk than control patients for developing conditions affecting major system of the body, according to a study of nearly 2 million patients.

The FDA this week revised the dates for several upcoming meetings of its vaccine advisory board to discuss pediatric COVID-19 vaccines.

In February, the CDC released provisional guidance for the use of pretomanid as part of the bedaquiline, pretomanid and linezolid (BPaL) regimen to treat drug-resistant tuberculosis.

Why is the patient receiving levofloxacin?

The CDC’s vaccine advisory committee voted Thursday to recommend that children aged 5 to 11 years receive a booster dose of the Pfizer-BioNTech COVID-19 vaccine.

Trained dogs were able to identify samples from people with COVID-19 with 92% accuracy in a randomized trial conducted in Finland, researchers reported.

The FDA on Tuesday authorized a booster shot of Pfizer and BioNTech’s COVID-19 vaccine for children aged 5 to 11 years.

The FDA declined a request to authorize an inexpensive generic antidepressant and obsessive-compulsive disorder medication for emergency use as an outpatient treatment for COVID-19.

Patients hospitalized for COVID-19 infection and those who survived other severe acute respiratory infections were at similarly higher risk for subsequent neuropsychiatric diagnoses and treatment, researchers reported in JAMA Psychiatry.

People living with HIV were less likely to receive inappropriate antibiotics for acute respiratory infections compared with people without HIV, especially when treated by an HIV clinician, researchers found.